After Ignoring Obama Scandals For 8 Years, Reporters Are Now Making Them Up About Trump

After Ignoring Obama Scandals For 8 Years, Reporters Are Now Making Them Up About Trump | Stock News & Stock Market Analysis - IBD:
"Fake News: 
For eight  years, it was virtually impossible to get reporters interested in legitimate Obama administration scandals. 
Now, they are so eager to run scandal stories about the incoming Trump administration that they are making them up.
Two stories from major news outlets demonstrate this.

• First is the New York Times hit piece on Trump's pick for Energy Secretary, Rick Perry. It claimed that until days after Perry accepted the job, he "knew almost nothing about" the fact that a key function of the Energy Department is the stewardship of the nation's nuclear arsenal. The story spread like wildfire, with journalists falling over each other to tweet out clever Perry put downs. What was the Times' alarming claim based on? Nothing more than a twisted interpretation of a single quote from one person: Michael McKenna, a Republican energy lobbyist who was canned form the Trump transition team before Perry was picked. McKenna himself has since said the Times misinterpreted what he said. ..The story was so egregiously wrong that even the liberal New York magazine took the Times to task for spreading a false rumor.

• Just days before, CNN ran a hit piece on Rep. Tom Price — Trump's pick to head the Health and Human Services Department — for supposedly engaging in insider trading last year. A "bombshell" story published on Tuesday — titled "First on CNN: Trump's pick invested in company, then introduced a bill to help it" — said Price had bought as much as $15,000 worth of shares in Zimmer Biomet (ZBH), a company that makes knee and hip replacements. Then, the story goes, he introduced the HIP Act, which would have delayed an ObamaCare regulation that would, if implemented, hurt Zimmer Biomet and other device makers. This, CNN reporter Manu Raju asserted, raised "new concerns among ethics experts that Price may have inappropriately used inside information while purchasing shares in a company." "When you look at the timeline, this raises significant questions," CNN's Erin Burnett said about the story. Sen. Charles Schumer responded to the CNN report with a call to delay Price's confirmation hearings until the congressional ethics office does a "thorough investigation." It's not as though this sort of self-dealing hasn't gone on in Washington. Peter Schweizer's 2011 book, "Throw Them All Out," was full of such examples, including lucrative stock trades by Nancy Pelosi, John Kerry and other prominent Democrats. Schweizer's book led to the STOCK Act in 2012, which tried to combat insider trading by lawmakers. The rest of the CNN story falls apart with just a cursory look at the facts. First, Price didn't buy those shares. His portfolio was managed by Morgan Stanley, which designed the account's investment strategy and directed all trades. As part of a routine rebalancing of Price's account in early 2016, Morgan Stanley bought 26 shares in Zimmer Biomet, worth a grand total of $2,697.74. (Price's net worth is on the order of $10 million.)..."